The Consumer’s Guide to CGRP Medications for Chronic Migraine
What you need to know about the only treatment option specifically developed for treating and preventing chronic migraine.
S ince 2018, when the U.S. Food and Drug Administration (FDA) approved the first calcitonin gene-related peptide (CGRP) antagonist for migraine disease, this class of drugs has revolutionized the prevention and treatment of both episodic and chronic migraine attacks.
The development of CGRP antagonists has “been a really exciting development in the headache world,” says Anne Yacoub, MD, codirector of the Johns Hopkins Headache Center in Baltimore.
Peter Goadsby, MD, PhD, a professor of neurology at King’s College in London and professor emeritus at the University of California in Los Angeles, adds, “If migraine is affecting your life, that can be changed with these drugs.”
CGRP antagonists help prevent a migraine attack in one of two ways: by either blocking CGRP, a key peptide in the brain that’s involved in triggering pain and other symptoms, or blocking the receptor in the brain that CGRP binds to, explains Dr. Yacoub. In both cases, an attack can be effectively relieved or prevented altogether.
6 Essential Facts About CGRPs for Migraine
1. CGRPs are the first drugs designed specifically to prevent migraine.
Before CGRPs hit the market, the only medications prescribed to prevent migraine were drugs that had originally been developed to treat other conditions, such as high blood pressure, epilepsy, or depression, says Dr. Goadsby. Researchers noticed these drugs seemed to help migraine and studied them for that, but when it came to adding them to the migraine disease arsenal, “We got there by accident, so we never really knew how they worked — and still don’t,” he says.
By contrast, CGRP antagonists were developed specifically for migraine, based on an understanding of the role CGRP peptides play in the disease.
2. Two types of CGRP migraine medications are available.
Four of each type are approved by the FDA, with the promise of more coming down the pike.
CGRP monoclonal antibodies, which prevent migraine:
- eptinezumab (Vyepti)
- erenumab (Aimovig)
- fremanezumab (Ajovy)
- galcanezumab (Emgality)
CGRP receptor antagonists (called gepants), which help prevent and relieve migraine:
- atogepant (Qulipta)
- rimegepant (Nurtec)
- ubrogepant (Ubrelvy)
- zavegepant (Zavzpret)
3. CGRP medications can be taken in a variety of ways.
This is a plus if you and your doctor decide you could benefit from trying a CGRP, because you’ll likely have options for how to take it and the flexibility to try something different if your original choice doesn’t work for you.
Orally (one tablet per day):
- atogepant (Qulipta)
- rimegepant (Nurtec)
- ubrogepant (Ubrelvy)
By injection (once a month):
- erenumab (Aimovig)
- fremanezumab (Ajovy)
- galcanezumab (Emgality)
By infusion (once every three months):
- eptinezumab (Vyepti)
As a nasal spray (once a day):
- zavegepant (Zavzpret)
4. CGRPs are highly effective.
CGRP medications for migraine have been found to have a trio of key benefits, research has found. Namely, they’ve been shown to reduce:
- Migraine frequency (the number of attacks that occur per month)
- Headache days (the number of days that an attack lasts the entire day)
- The need for migraine attack treatment
But that’s not all. “Migraine is a complex neurological disorder with many manifestations. Pain is one of them, but so are light or sound sensitivity, cognitive thinking dysfunction, brain fog, a dreadful sense of fatigue, and a sense of being sleepy,” notes Goadsby. “So, when we say CGRPs are effective, they don’t just reduce the pain days and severity; they also reduce all of those other symptoms.”
5. CGRP medications cause few side effects.
CGRP drugs are well tolerated, says Yacoub, especially compared with other migraine treatments. “The older medicines are more side-effect prone,” Goadsby adds.
Research shows a substantial number of people who have migraine disease either don’t respond to other treatments or can’t tolerate them. But a study published in The Lancet found that participants who took an erenumab CGRP or a placebo had a roughly equal reaction.
A review published in 2023 in the Saudi Journal of Medicine and Medical Sciences reported the most common side effects as nausea, upper respiratory tract infection, constipation, fatigue, and mild skin reactions at the injection site. And only a small percentage of people who take CGRPs appear to experience side effects, based on the FDA Adverse Event Reporting System.
If you do experience side effects from a CGRP migraine drug, the benefits are likely to outweigh the risks. And there are steps you can take to help mitigate mild side effects, such as constipation, which is especially common.
In that case, “You can change your diet. You can change your exercise habits,” suggests Goadsby. Or, if you have a reaction at the injection site, a warm compress or anti-itch medication could relieve it.
6. CGRP migraine drugs work quickly.
Most people who try a CGRP medication for migraine notice an improvement within the first month of starting the drug. That said, it may take three months, or sometimes more, to get the full benefit — meaning very few migraine attacks or even none at all.
“If you get a response straightaway, congratulations,” says Goadsby. “But if you don’t, being patient will be rewarded. I advise people to at least [stick with it] for three months, but the data suggests that you’re really better off [going] four or five months to be absolutely sure.”
Is a CGRP Migraine Medication Right for You?
Of course, whether you try a CGRP medication ultimately will be based on conversations you and your doctor have about your personal situation.
6 Frequently Asked Questions About CGRP Migraine Medications
Next Steps: Making Migraine Treatment Decisions
Congratulations!
Now that you’ve learned more about CGRPs, take some time to think about how much of an impact migraine has on your life and what you might want to discuss with your doctor.
Self-Reflection
Ask yourself these questions before your next appointment.
- How well do my current migraine medications seem to be working?
- How many migraine days am I still having?
- How often am I experiencing symptoms outside of pain — light or sound sensitivity, brain fog, fatigue?
- Have my symptoms improved or gotten worse since my last checkup?
- How often do I call out of work or cancel plans due to migraine?
Doctor Discussion
Keep these questions in mind to ask at your next checkup.
- Am I a candidate for CGRP medication?
- Are there any other treatments I need to try before starting a CGRP?
- Would any of the other medications I take interact with these drugs?
- Is there anything else I can do to help ease my migraine symptoms?